Literature DB >> 24948005

Update on crescentic glomerulonephritis.

Carole Hénique1, Christina Papista, Léa Guyonnet, Olivia Lenoir, Pierre-Louis Tharaux.   

Abstract

The recent years have seen a number of major progresses in the field of extracapillary glomerulonephritis. This entity is the final damage caused by unrelated immunological disorders such as immune complexes glomerular deposits or microvascular injury caused by proinflammatory cytokines, neutrophil extracellular traps (NET), and cell adhesion molecules in the context of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). This review provides a summary of recent advances in the understanding of crescentic glomerulonephritis, focusing on interplays of local immune cells and on local mediators participating to crescent formation especially in anti-glomerular basement membrane (anti-GBM) antibody disease. The recent advances about AAV and lupus nephritis are covered by other chapters of this issue. Nevertheless, these considerations may apply to the general case of crescentic glomerulonephritis of all causes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24948005     DOI: 10.1007/s00281-014-0435-7

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  99 in total

Review 1.  Monocyte and macrophage biology: an overview.

Authors:  Andrew J Rees
Journal:  Semin Nephrol       Date:  2010-05       Impact factor: 5.299

Review 2.  Basic and translational concepts of immune-mediated glomerular diseases.

Authors:  William G Couser
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

3.  Both IgG- and C1q-receptors play a role in the enhanced binding of IgG complexes to human mesangial cells.

Authors:  M E van den Dobbelsteen; F J van der Woude; W E Schroeijers; N Klar-Mohamad; L A van Es; M R Daha
Journal:  J Am Soc Nephrol       Date:  1996-04       Impact factor: 10.121

4.  Cellular composition of crescents in human rapidly progressive glomerulonephritis identified using monoclonal antibodies.

Authors:  W W Hancock; R C Atkins
Journal:  Am J Nephrol       Date:  1984       Impact factor: 3.754

5.  Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice.

Authors:  Mei Ding; Shiying Cui; Chengjin Li; Serge Jothy; Volker Haase; Brent M Steer; Philip A Marsden; Jeffrey Pippin; Stuart Shankland; Maria Pia Rastaldi; Clemens D Cohen; Matthias Kretzler; Susan E Quaggin
Journal:  Nat Med       Date:  2006-08-13       Impact factor: 53.440

6.  MHC class I pathway is not required for the development of crescentic glomerulonephritis in mice.

Authors:  S Li; S R Holdsworth; P G Tipping
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

7.  Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes.

Authors:  Leendert A Trouw; Tom W L Groeneveld; Marc A Seelen; Jacques M G J Duijs; Ingeborg M Bajema; Frans A Prins; Uday Kishore; David J Salant; J Sjef Verbeek; Cees van Kooten; Mohamed R Daha
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

8.  Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases.

Authors:  Naotake Tsuboi; Kenichi Asano; Michael Lauterbach; Tanya N Mayadas
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

Review 9.  Influence of the mannose receptor in host immune responses.

Authors:  Umut Gazi; Luisa Martinez-Pomares
Journal:  Immunobiology       Date:  2009-01-21       Impact factor: 3.144

10.  Analysis of T cell responses to the autoantigen in Goodpasture's disease.

Authors:  C J Derry; C N Ross; G Lombardi; P D Mason; A J Rees; R I Lechler; C D Pusey
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

View more
  11 in total

1.  Nuclear Factor Erythroid 2-Related Factor 2 Drives Podocyte-Specific Expression of Peroxisome Proliferator-Activated Receptor γ Essential for Resistance to Crescentic GN.

Authors:  Carole Henique; Guillaume Bollee; Olivia Lenoir; Neeraj Dhaun; Marine Camus; Anna Chipont; Kathleen Flosseau; Chantal Mandet; Masayuki Yamamoto; Alexandre Karras; Eric Thervet; Patrick Bruneval; Dominique Nochy; Laurent Mesnard; Pierre-Louis Tharaux
Journal:  J Am Soc Nephrol       Date:  2015-05-21       Impact factor: 10.121

Review 2.  Basement membranes and autoimmune diseases.

Authors:  Mary H Foster
Journal:  Matrix Biol       Date:  2016-08-02       Impact factor: 11.583

3.  Ten-year advances in immunopathology of glomerulonephritis: translated into patients' care or lost in translation?

Authors:  Pierre Ronco; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2014-07-24       Impact factor: 9.623

4.  Clinical value of urinary cytokines/chemokines as prognostic markers in patients with crescentic glomerulonephritis.

Authors:  Junseok Jeon; Jeeeun Park; Hyo Jin Boo; Kyeong Eun Yang; Cheol-Jung Lee; Jung Eun Lee; Kyunga Kim; Ghee Young Kwon; Wooseong Huh; Dae Joong Kim; Yoon-Goo Kim; Hye Ryoun Jang
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

Review 5.  Pauci-immune glomerulonephritis in a captive chimpanzee (Pan troglodytes), and a review of spontaneous cases in animals.

Authors:  Lauren E Neidig; Michael A Owston; Erin Ball; Edward J Dick
Journal:  J Med Primatol       Date:  2016-08-10       Impact factor: 0.667

Review 6.  Optimizing the translational value of animal models of glomerulonephritis: insights from recent murine prototypes.

Authors:  Mary H Foster
Journal:  Am J Physiol Renal Physiol       Date:  2016-06-22

7.  Low Serum Complement C3 Levels at Diagnosis of Renal ANCA-Associated Vasculitis Is Associated with Poor Prognosis.

Authors:  Jean-François Augusto; Virginie Langs; Julien Demiselle; Christian Lavigne; Benoit Brilland; Agnès Duveau; Caroline Poli; Alain Chevailler; Anne Croue; Frederic Tollis; Johnny Sayegh; Jean-François Subra
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

Review 8.  Kidney disease models: tools to identify mechanisms and potential therapeutic targets.

Authors:  Yin-Wu Bao; Yuan Yuan; Jiang-Hua Chen; Wei-Qiang Lin
Journal:  Zool Res       Date:  2018-03-18

Review 9.  Podocyte Injury in Lupus Nephritis.

Authors:  Hamza Sakhi; Anissa Moktefi; Khedidja Bouachi; Vincent Audard; Carole Hénique; Philippe Remy; Mario Ollero; Khalil El Karoui
Journal:  J Clin Med       Date:  2019-08-29       Impact factor: 4.241

10.  Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis.

Authors:  Lucia Tejedor-Santamaria; Jose Luis Morgado-Pascual; Laura Marquez-Exposito; Beatriz Suarez-Alvarez; Raul R Rodrigues-Diez; Antonio Tejera-Muñoz; Vanessa Marchant; Sergio Mezzano; Carlos Lopez-Larrea; Anna Sola; Gema Maria Fernandez-Juarez; Alberto Ortiz; Sandra Rayego-Mateos; Marta Ruiz-Ortega
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.